C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01)
Patent
CA 2535650
The present invention provides antisense oligonucleotides directed to a mammalian ribonucleotide reductase R2 gene and combinations of the antisense oligonucleotides with one or more chemotherapeutic agents for use in the treatment of cancer.
L'invention porte: sur des oligonucléotides antisens se dirigeant vers le gène de ribonucléotide réductase R2 de mammifère, et sur leur combinaison, avec un ou plusieurs agents de chimiothérapie, utilisée pour le traitement du cancer.
Wright Jim A.
Young Aiping H.
Genesense Technologies Inc.
Lorus Therapeutics Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Antisense oligonucleotides directed against ribonucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides directed against ribonucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides directed against ribonucleotide... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2049802